Herpetic Keratitis: The Genesis of a Career in the Early Days of HSV Keratitis Research

  • Peter R. Laibson


I met Claes Dohlman for the first time at an antiviral conference in 1963 sponsored by Allergan Pharmaceuticals in Irvine, California. We had both been invited to discuss the first antiviral drug effective against a human virus, herpes simplex. The medication was 5-iodo-2′-deoxyuridine, or IDU. It had initially been reported by Kaufman, Nesburn, and Maloney in 1962 [1], while Herbert Kaufman was an ophthalmology resident at Massachusetts Eye and Ear Infirmary.


Herpes keratitis Herpes simplex virus HSV Antiviral therapy Corneal inflammation 


  1. 1.
    Kaufman HE, Nesburn AB, Mahoney ED. IDU therapy of herpes simplex keratitis. Arch Ophthalmol. 1962;67:583–91.CrossRefPubMedGoogle Scholar
  2. 2.
    Laibson PR, Sery TW, Leopold IH. The treatment of herpetic keratitis with IDU. Arch Ophthalmol. 1963;70:52–8.CrossRefGoogle Scholar
  3. 3.
    Gunderson T. Herpes cornea with special reference to its treatment with strong solution of iodine. ArchOphthalmol. 1936;15:225–44.Google Scholar
  4. 4.
    Sery T. Chemotherapy of virus infections. In: IntOphthClin, 1961, vol. 1; 1961. p. 99–110.Google Scholar
  5. 5.
    Laibson PR, Leopold IH. An evaluation of double-Blind IDU therapy in 100 cases of herpetic keratitis. Trans AmAcadOphthalmolOtolaryngol. 1964:22–33.Google Scholar
  6. 6.
    Carroll J, Martola EL, Laibson PR, Dohlman CH. The recurrence of herpetic keratitis following IDU therapy. Am JOphthalmol. 1967;63:103–7.CrossRefGoogle Scholar
  7. 7.
    Laibson PR, Kibrick S. Reactivation of herpetic keratitis by epinephrine in rabbit. Arch Ophthalmol. 1966;75:254–60.CrossRefPubMedGoogle Scholar
  8. 8.
    Laibson PR, Kibrick S. Reactivation of herpetic keratitis in rabbits II. Repeated reactivations in the same host. Arch Ophthalmol. 1967;77:244–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Pavan-Langston D, Dohlman CH. A double-Blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. Am J Ophthalmol. 1972;74:81–8.CrossRefGoogle Scholar
  10. 10.
    Hyndiuk RA, Hull DS, Schultz R, et al. Adenine arabinoside in IDU unresponsive and IDU intolerant herpetic keratitis. Am J Ophthalmol. 1975;79:655–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Kaufman HE, Heidelberger C. Therapeutic antiviral action of 5 trifluoro- methyl-2 deoxyuridine in herpes simplex keratitis. Science. 1964;145:585.CrossRefPubMedGoogle Scholar
  12. 12.
    Parlato CJ, Cohen EJ, Sakauye CM, et al. Role of debridement and trifluridine (Trifluorothymidine) in herpes simplex dendritic keratitis. Arch Ophthalmol. 1985;103:673–5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Peter R. Laibson
    • 1
  1. 1.Department of CorneaWills Eye HospitalPhiladelphiaUSA

Personalised recommendations